Access cutting-edge hemophilia b treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access hemophilia b specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hemophilia b treatment provided free
Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B. This study is researching an experimental gene insertion therapy (the adding of a gene into your DNA) called REGV131-LNP1265, also called the "study drug". Gene insertion therapy aims to teach the body how to produce clotting factor long-term, without the need for factor replacement therapy. The main aim of this study is to find
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this hemophilia b clinical trial in San Francisco, CA
If you're searching for hemophilia b treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hemophilia b specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.